India may authorise foreign Covid-19 vaccines for emergency use within 3 working days of application
The decision is a part of the fast track approval policy of the government for the foreign Covid-19 vaccine candidates in the country.
The decision is a part of the fast track approval policy of the government for the foreign Covid-19 vaccine candidates in the country.
Vaccination is one of the critical pillars of COVID control and management strategy adopted by the Centre. Presently two vaccines i.e. Covaxin by Bharat Biotech International Limited (BBIL) and Covishield by Serum Institute of India (SII), have received Emergency Use Authorization (EUA) from the National Regulator (Drugs Controller General of India).
